Analysis

Two Agencies, Two 'Nascent Competitor' Merger Challenges

Law360 (December 18, 2019, 10:40 PM EST) -- With the Federal Trade Commission's move Tuesday to block DNA-sequencing company Illumina's proposed $1.2 billion takeover of PacBio, both U.S. antitrust agencies are now in the unusual position of trying to stop a big company from scooping up a nascent competitor.

The FTC's action comes on the heels of a U.S. Department of Justice lawsuit challenging Sabre Corp.'s planned $360 million acquisition of airline booking company Farelogix Inc. Challenges of so-called killer acquisitions are relatively rare, but now each federal antitrust enforcer is pursuing one amid heated criticism that the agencies have stood by while dominant firms buy out potential rivals...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!